Stockscreener 앱 받기
9.51
3.94%
-0.39
시간 외 거래:
9.51
전일 마감가:
$9.90
열려 있는:
$9.89
하루 거래량:
684.06K
Relative Volume:
0.80
시가총액:
$827.80M
수익:
-
순이익/손실:
$-106.81M
주가수익비율:
-2.8716
EPS:
-3.3117
순현금흐름:
$-8.40M
1주 성능:
-7.67%
1개월 성능:
-10.28%
6개월 성능:
+6.97%
1년 성능:
-37.60%
1일 변동 폭
$9.41
$9.99
1주일 범위
$9.41
$10.52
52주 변동 폭
$5.1501
$16.73
이뮤놈 Stock (IMNM) Company Profile
명칭
Immunome Inc
전화
610-321-3700
주소
18702 N. CREEK PARKWAY, BOTHELL
IMNM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
9.51 | 861.75M | 0 | -106.81M | -8.40M | -3.3117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
이뮤놈 Stock (IMNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-02 | 개시 | Lake Street | Buy |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-04-30 | 개시 | JP Morgan | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-01-29 | 개시 | Leerink Partners | Outperform |
| 2023-12-19 | 개시 | Wedbush | Outperform |
| 2021-10-29 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
이뮤놈 주식(IMNM)의 최신 뉴스
Regression analysis insights on Immunome Inc. performanceJuly 2025 PreEarnings & Long-Term Investment Growth Plans - Newser
What Fibonacci levels say about Immunome Inc. rebound2025 Retail Activity & Safe Entry Point Alerts - Newser
Is Immunome Inc. trending in predictive chart modelsMarket Growth Review & Fast Exit and Entry Trade Guides - Newser
Using data filters to optimize entry into Immunome Inc.2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
Price momentum metrics for Immunome Inc. explainedTrade Analysis Report & Proven Capital Preservation Methods - Newser
Immunome Inc.’s volatility index tracking explainedMarket Activity Report & Target Return Focused Stock Picks - Newser
Will Immunome Inc. continue its uptrendEarnings Risk Summary & Weekly Top Gainers Alerts - Newser
Using Bollinger Bands to evaluate Immunome Inc.Volume Spike & Weekly Breakout Watchlists - Newser
Analyzing net buyer seller activity in Immunome Inc.Weekly Trade Review & Free Technical Confirmation Trade Alerts - Newser
Short interest data insights for Immunome Inc.Trade Volume Report & Reliable Volume Spike Trade Alerts - Newser
Why Immunome Inc. stock attracts strong analyst attentionQuarterly Portfolio Report & High Accuracy Trade Signal Alerts - Newser
Is Immunome Inc. building a consolidation baseQuarterly Trade Report & AI Driven Stock Movement Reports - Newser
Will Immunome Inc. stock recover after recent dropWeekly Risk Summary & Daily Price Action Insights - Newser
Does Immunome Inc. qualify in momentum factor screening2025 Support & Resistance & Fast Gaining Stock Reports - Newser
Best data tools to analyze Immunome Inc. stockWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Is Immunome Inc. a candidate for recovery playEarnings Miss & Risk Managed Trade Strategies - Newser
Will Immunome Inc. bounce back from current supportWeekly Stock Report & High Accuracy Swing Trade Signals - Newser
Analyzing recovery setups for Immunome Inc. investorsStop Loss & Daily Chart Pattern Signal Reports - Newser
Will breakout in Immunome Inc. lead to full recoveryJuly 2025 WrapUp & Weekly Watchlist of Top Performers - Newser
How to build a dashboard for Immunome Inc. stockMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
이뮤놈 (IMNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):